Prenatal maternal dried blood screening with α-fetoprotein and free β- human chorionic gonadotropin for open neural tube defect and Down syndrome

American Journal of Obstetrics and Gynecology

Volumn 174, Issue 2, 1996, Pages 566-572

  Macri, J N ^a   Anderson, R W ^a   Krantz, D A ^a   Larsen, J W ^a   Buchanan, P D ^a  

^a NTD Laboratories Inc ^*  (United States)

Author keywords

Dried blood spot; free human chorionic gonadotropin; prenatal screening; fetoprotein

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; ARTICLE; CLINICAL PROTOCOL; DOWN SYNDROME; FETUS; GENETIC SCREENING; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MATERNAL BLOOD; NEURAL TUBE DEFECT; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY;

EID: 0030029409     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(96)70429-5     Document Type: Article

References (15)

1. IR Merkatz HM Nitkowski JN Macri WE Johnson An association between low maternal serum α-fetoprotein and fetal chromosome abnormalities AM J OBSTET GYNECOL 148 1984 886 894
2. JN Macri Critical issues in prenatal maternal serum α-fetoprotein screening for genetic abnormalities AM J OBSTET GYNECOL 155 1986 240 246
3. HS Cuckle NJ Wald SG Thompson Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level Br J Obstet Gynaecol 94 1987 387 402
4. MH Bogart MR Pandian OW. Jones Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities Prenat Diagn 7 1987 623 630
5. JA Canick GJ Knight GE Palomaki JE Haddow HS Cuckle NJ Wald Low second trimester maternal serum unconjugated estriol in pregnancies with Down's syndrome Br J Obstet Gynaecol 95 1988 330 333
6. JN Macri RV Kasturi DA Krantz Maternal serum Down syndrome screening: free β-protein is a more effective marker than human chorionic gonadotropin AM J OBSTET GYNECOL 163 1990 1248 1253
7. JN Macri K Spencer K Garver Maternal serum free beta hCG screening: results of studies including 480 cases of Down syndrome Prenat Diagn 14 1994 97 103
8. MJ Adams GC Windham LM James Clinical interpretation of maternal serum α-fetoprotein concentrations AM J OBSTET GYNECOL 148 1984 241 243
9. K Spencer JN Macri P Carpenter R Anderson D. Krantz Stability of intact chorionic gonadotropin (hCG) in serum, liquid whole blood, and dried whole blood filter-paper spots: impact on screening for Down syndrome by measurement of free beta-hCG subunit Clin Chem 39 1993 1064 1068
10. NJ Wald A Kennard JW Densem HS Cuckle T Chard L Butler Antenatal maternal serum screening for Down's syndrome: results of a demonstration project BMJ 305 1992 391 394
11. JE Haddow GE Palomaki GJ Knight Prenatal screening for Down's syndrome with use of maternal serum markers N Engl J Med 327 1992 588 593
12. SF Goodburn JRW Yates PR Raggatt Second trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme Prenat Diagn 14 1994 391 402
13. KD Wenstrom RA Williamson SS Grant JD Hudson JP. Getchell Evaluation of multiple-marker screening for Down syndrome in a statewide population AM J OBSTET GYNECOL 169 1993 793 797
14. A Verloes R Schoos C Herens A Vintens L Koulischer A prenatal trisomy 21 screening program using α-fetoprotein, human chorionic gonadotropin, and free estriol assays on maternal dried blood AM J OBSTET GYNECOL 172 1995 167 174
15. NJ Wald JW Densem D Smith GG Klee Four marker serum screening for Down's syndrome Prenat Diagn 14 1994 707 716